logo inner

Discovery-Lentiviral Vector Development Intern

ArcellxRockville, MdOnsite
This job is no longer open

Who We Are


Arcellx isa public, clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. We believe that cell therapies are one of the forward pillars of medicine and our mission is to destroy cancer and advance humanity by developing cell therapies that are safer, more effective, and more broadly accessible. Our team members are made up of talented innovators and dreamers working from our offices in Rockville, Maryland, and Redwood City, California.

At Arcellx, we hire exceptional people and create a fun, diverse, supportive, and informal environment that allows everyone to do their best work. 

What Matters to Us


Living our core values is essential to maintaining a work environment that is high-performing, inclusive, and collaborative. We look for candidates who demonstrate strong values alignment and bring different backgrounds, viewpoints, and abilities to the team.Arcellx Core Values

  • Character: Committed to always doing what’s right. 
  • Audacity: Willing to challenge convention and share candid feedback with others.
  • Determination: Curious and self-motivated. Always looking to improve and learn.   
  • Collaboration: "No job is too small" mentality. Humble and willing to help others.
  • Originality: Will bring your unique perspective to the table and respect a diverse set of views and backgrounds. 

The “Fine Print” – What You’ll Do


  • Design, generate, and characterizelentiviral vectors for use in cell therapy.
  • Produce research-scale lentivirus, analyze lentiviral quality, determine viral integration, and check expression levels of payload in cell lines.
  • Utilize common software including GraphPad Prism, Word, PowerPoint, Excel, andFlowJo to analyze, record, and present your results.
  • Communicate detailed observations on experiments and assist in the preparation of technical reports, summaries, and protocols.
  • Work both independently and collaboratively, and effectively plan, organize work activities, and prioritize task completion.

Skills and Experience We Look For


Our ideal candidate has anenthusiasm for scientific discovery, interest in biotechnology, knowledge of the field, familiarity with molecular biology and cell culture techniques, is well-organized, works well with a team, and has the initiative to individually drive a project forward.

  • Undergraduate or Master’s degree-level courseworkcovering the concepts behind immunotherapy, and cell therapy.
  • Familiarity with molecular biology methods, including primer design, PCR, gel electrophoresis, plasmid DNA preparation, cloning, and sequence analysis using SnapGene or similar software.
  • Experience with aseptic cell culture and understanding ofDNA transfection, and lentiviral transduction methods.
  • Preferred knowledge ofadditional methods including DNA extraction and real-time PCR analysis, flow cytometry, and bioinformatics.

Join us in our quest to reimagine cell therapy and destroy cancer. For more on our technology, culture, and team, go to


www.arcellx.com



 #LI-Onsite

This job is no longer open

Life at Arcellx

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. The Company's proprietary ARC-sparX platform separates the tumor-recognition and tumor-killing functions of conventional CAR-T cell therapies: (1) sparX (soluble protein antigen-receptor X-linkers) proteins recognize and bind specific antigens on diseased cells and flag those cells for destruction; and (2) ARC-T (Antigen Receptor Complex-T) cells bind the sparX proteins and kill the flagged cells. Arcellx has developed a collection of sparX proteins that bind different cell surface antigens. Administration of alternate sparX proteins can redirect ARC-T cells to different disease antigens to potentially address relapsed and refractory disease due to tumor heterogeneity or antigen escape. Additionally, ARC-T cell activity can be curbed as needed by controlling the dose and frequency of sparX administration.
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024